"It is also understood that specifically binding to a ??2GPI-dependent antiphospholipid antibody may be demonstrated by using a fragment or other recombinant product of a ??2GPI-dependent antiphospholipid antibody, such as an Fab fragment, or single chain variable region constructs (scFv), which are known in the art." . . . .